title: RHU GM-CSF shortens aplasia duration after ABMT in non-Hodgkin's lymphoma: a randomized placebo-controlled double-blind study.
authors.affiliation: Hôpital Saint-Antoine, France.
authors.forename: N C
authors.initials: NC
authors.lastname: Gorin
authors.forename: B
authors.initials: B
authors.lastname: Coiffier
authors.forename: M
authors.initials: M
authors.lastname: Hayat
authors.forename: T
authors.initials: T
authors.lastname: Philip
authors.forename: J P
authors.initials: JP
authors.lastname: Vernant
authors.forename: P
authors.initials: P
authors.lastname: Hervé
authors.forename: P
authors.initials: P
authors.lastname: Colombat
authors.forename: P
authors.initials: P
authors.lastname: Boivin
authors.forename: S
authors.initials: S
authors.lastname: Slavin
authors.forename: I
authors.initials: I
authors.lastname: Eugène-Jolchine
mesh_terms: D016026:Bone Marrow Transplantation; D004311:Double-Blind Method; D006085:Graft Survival / Q000187:drug effects; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D007958:Leukocyte Count / Q000187:drug effects; D008228:Lymphoma, Non-Hodgkin / Q000601:surgery*; D009504:Neutrophils; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D014182:Transplantation, Autologous
chemical_list: D007155:Immunologic Factors; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor